OBJECTIVE: To determine whether patient's demographics or severity of illness predict hospital readmission within 30 days following spontaneous intracerebral hemorrhage, to identify readmission associations that may be modifiable at the single-center level, and to determine the impact of readmission on outcomes. DESIGN: We collected demographic, clinical, and hospital course data for consecutive patients with spontaneous intracerebral hemorrhage enrolled in an observational study. Readmission within 30 days was determined retrospectively by an automated query with manual confirmation. We identified the reason for readmission and tested for associations between readmission and functional outcomes using modified Rankin Scale (a validated functional outcome measure from 0, no symptoms, to 6, death) scores before intracerebral hemorrhage and at 14 days, 28 days, and 3 months after intracerebral hemorrhage. SETTING: Neurologic ICU of a tertiary care hospital. PATIENTS: Critically ill patients with spontaneous intracerebral hemorrhage. INTERVENTIONS: Patients received standard critical care management for intracerebral hemorrhage. MEASUREMENTS AND MAIN RESULTS: Of 246 patients (mean age, 65 yr; 51% female), 193 patients (78%) survived to discharge. Of these, 22 patients (11%) were readmitted at a median of 9 days (interquartile range, 4-15 d). The most common readmission diagnoses were infections after discharge (n = 10) and vascular events (n = 6). Age, history of stroke and hypertension, severity of neurologic deficit at admission, Acute Physiology and Chronic Health Evaluation score, ICU and hospital length of stay, ventilator-free days, days febrile, and surgical procedures were not predictors of readmission. History of coronary artery disease was associated with readmission (p = 0.03). Readmitted patients had similar modified Rankin Scale and severity of neurologic deficit at 14 days but higher (worse) modified Rankin Scale scores at 3 months (median [interquartile range], 5 [3-6] vs 3 [1-4]; p = 0.01). CONCLUSIONS: Severity of illness and hospital complications were not associated with 30-day readmission. The most common indication for readmission was infection after discharge, and readmission was associated with worse functional outcomes at 3 months. Preventing readmission after intracerebral hemorrhage may depend primarily on optimizing care after discharge and may improve functional outcomes at 3 months.
OBJECTIVE: To determine whether patient's demographics or severity of illness predict hospital readmission within 30 days following spontaneous intracerebral hemorrhage, to identify readmission associations that may be modifiable at the single-center level, and to determine the impact of readmission on outcomes. DESIGN: We collected demographic, clinical, and hospital course data for consecutive patients with spontaneous intracerebral hemorrhage enrolled in an observational study. Readmission within 30 days was determined retrospectively by an automated query with manual confirmation. We identified the reason for readmission and tested for associations between readmission and functional outcomes using modified Rankin Scale (a validated functional outcome measure from 0, no symptoms, to 6, death) scores before intracerebral hemorrhage and at 14 days, 28 days, and 3 months after intracerebral hemorrhage. SETTING: Neurologic ICU of a tertiary care hospital. PATIENTS: Critically illpatients with spontaneous intracerebral hemorrhage. INTERVENTIONS:Patients received standard critical care management for intracerebral hemorrhage. MEASUREMENTS AND MAIN RESULTS: Of 246 patients (mean age, 65 yr; 51% female), 193 patients (78%) survived to discharge. Of these, 22 patients (11%) were readmitted at a median of 9 days (interquartile range, 4-15 d). The most common readmission diagnoses were infections after discharge (n = 10) and vascular events (n = 6). Age, history of stroke and hypertension, severity of neurologic deficit at admission, Acute Physiology and Chronic Health Evaluation score, ICU and hospital length of stay, ventilator-free days, days febrile, and surgical procedures were not predictors of readmission. History of coronary artery disease was associated with readmission (p = 0.03). Readmitted patients had similar modified Rankin Scale and severity of neurologic deficit at 14 days but higher (worse) modified Rankin Scale scores at 3 months (median [interquartile range], 5 [3-6] vs 3 [1-4]; p = 0.01). CONCLUSIONS: Severity of illness and hospital complications were not associated with 30-day readmission. The most common indication for readmission was infection after discharge, and readmission was associated with worse functional outcomes at 3 months. Preventing readmission after intracerebral hemorrhage may depend primarily on optimizing care after discharge and may improve functional outcomes at 3 months.
Authors: Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks Journal: Stroke Date: 2007-04-12 Impact factor: 7.914
Authors: Paula M Janssen; Nora A Visser; Sanne M Dorhout Mees; Catharina J M Klijn; Ale Algra; Gabriel J E Rinkel Journal: Cerebrovasc Dis Date: 2009-12-01 Impact factor: 2.762
Authors: Andrew M Naidech; Borko Jovanovic; Storm Liebling; Rajeev K Garg; Sarice L Bassin; Bernard R Bendok; Richard A Bernstein; Mark J Alberts; H Hunt Batjer Journal: Stroke Date: 2009-05-14 Impact factor: 7.914
Authors: Amy J H Kind; Maureen A Smith; Jinn-Ing Liou; Nancy Pandhi; Jennifer R Frytak; Michael D Finch Journal: J Am Geriatr Soc Date: 2008-04-18 Impact factor: 5.562
Authors: Santosh B Murthy; Ivan Diaz; Xian Wu; Alexander E Merkler; Costantino Iadecola; Monika M Safford; Kevin N Sheth; Babak B Navi; Hooman Kamel Journal: Stroke Date: 2019-11-27 Impact factor: 7.914
Authors: Aaron S Lord; Ariane Lewis; Barry Czeisler; Koto Ishida; Jose Torres; Hooman Kamel; Daniel Woo; Mitchell S V Elkind; Bernadette Boden-Albala Journal: Stroke Date: 2016-06-14 Impact factor: 7.914
Authors: Jacob K Greenberg; Ridhima Guniganti; Eric J Arias; Kshitij Desai; Chad W Washington; Yan Yan; Hua Weng; Chengjie Xiong; Emily Fondahn; DeWitte T Cross; Christopher J Moran; Keith M Rich; Michael R Chicoine; Rajat Dhar; Ralph G Dacey; Colin P Derdeyn; Gregory J Zipfel Journal: J Neurosurg Date: 2016-08-05 Impact factor: 5.115
Authors: Kathryn A Morbitzer; J Dedrick Jordan; Kelly A Sullivan; Emily A Durr; Casey M Olm-Shipman; Denise H Rhoney Journal: Neurocrit Care Date: 2016-10 Impact factor: 3.210
Authors: Mandeep Singh; James C Guth; Eric Liotta; Adam R Kosteva; Rebecca M Bauer; Shyam Prabhakaran; Neil Rosenberg; Bernard R Bendok; Matthew B Maas; Andrew M Naidech Journal: Neurocrit Care Date: 2013-12 Impact factor: 3.210
Authors: Melvin Parasram; Neal S Parikh; Alexander E Merkler; Guido J Falcone; Kevin N Sheth; Babak B Navi; Hooman Kamel; Cenai Zhang; Santosh B Murthy Journal: Neurohospitalist Date: 2021-06-25